CXS Insider Trading Activity and SEC Form 4 Filings
CXS insider trading summary
No open-market insider purchases or sales of CreXus Investment Corp. (CXS) have been reported on SEC Form 4 in the past 12 months.
Latest CXS insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| May 7, 2012 | Ronald Daniel Kazel | Director | Buy | $23K (2,225 @ $10.15) |
| Nov 16, 2011 | Patrick J Corcoran | Director | Buy | $50K (5,000 @ $9.90) |
| Nov 10, 2011 | Robert B Eastep | Director | Buy | $5K (500 @ $9.94) |
| Aug 12, 2011 | Robert M Karner | Head of Investments | Buy | $441K (45,000 @ $9.79) |
| Aug 11, 2011 | Daniel Wickey | CFO and Secretary | Buy | $7K (750 @ $9.56) |
| Aug 8, 2011 | Robert B Eastep | Director | Buy | $9K (1,000 @ $9.11) |
| Aug 5, 2011 | Jeffrey Conti | Head of Commercial Underwrtng | Buy | $24K (2,500 @ $9.77) |
| Aug 5, 2011 | Nancy Jo Kuenstner | Director | Buy | $15K (1,500 @ $9.74) |
| Aug 3, 2011 | Robert B Eastep | Director | Buy | $11K (1,000 @ $10.50) |
| Aug 3, 2011 | Ronald Daniel Kazel | Director | Buy | $73K (6,850 @ $10.59) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.